Learn More
Medchemexpress LLC 9-Hexadecenoic acid, 1,1'-[(9,10-dihydro-5,8-dihydroxy-9,10-dioxo-1,4-anthracenediyl)bis(imino-2,1-ethanediy... | 1349197-90-5 | 98.37% | 917.27 | 25 MG

Supplier: Medchemexpress LLC 25MGHY148702
di-Pal-MTO is a palm oil-based lipid created by combining the anticancer agent mitoxantrone (MTO) with palmitoleic acid. When nanoparticles of mono-Pal-MTO and di-Pal-MTO are combined in a molar ratio of 1:1, they effectively deliver siRNA to cells and enhance anticancer activity.
- Effective siRNA cell delivery
- Enhances anticancer activity
- Reduces tumor cell viability by 81% in vitro
- Reduces tumor size by 83% in vitro
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.